Fairpointe Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$20.3M |
| 2 |
NATI
National Instruments Corp
NATI
|
+$17.7M |
| 3 |
Corning
GLW
|
+$16.6M |
| 4 |
CVSA
Covista Inc
CVSA
|
+$9.5M |
| 5 |
Qiagen
QGEN
|
+$9.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKQ Corp
LKQ
|
+$36.9M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$36.1M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$35.9M |
| 4 |
Molson Coors Class B
TAP
|
+$34.9M |
| 5 |
Quest Diagnostics
DGX
|
+$33.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Industrials | 16.75% |
| 3 | Consumer Discretionary | 14.95% |
| 4 | Communication Services | 12.64% |
| 5 | Consumer Staples | 11.84% |
Similar funds
Fairpointe Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Fairpointe Capital held 84 positions worth $1.3B, down 34% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Fairpointe Capital withdrew a net $748M in Q4 2019, closing 8 positions and reducing 47 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $28.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Fairpointe Capital opened a new position in National Instruments Corp worth $17.9M.
- Fairpointe Capital's largest Q4 2019 buy was National Instruments Corp: 423,517 shares worth $17.9M.
- Fairpointe Capital added most to Pentair in Q4 2019, an estimated $20.3M increase.
- Fairpointe Capital's biggest Q4 2019 reduction was LKQ Corp, cutting an estimated $36.9M.
- Fairpointe Capital fully exited Nuance Communications, Inc. in Q4 2019, selling an estimated $28.2M.
- Fairpointe Capital's ten largest holdings make up 32% of its $1.3B portfolio in Q4 2019.
- Fairpointe Capital opened 4 new positions and closed 8 in Q4 2019.
- Fairpointe Capital's portfolio value fell 34% quarter-over-quarter to $1.3B.
Based on Fairpointe Capital's 13F filing for Q4 2019, filed 14 Feb 2020.